Literature DB >> 11265645

Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.

F J Staal1, J Meeldijk, P Moerer, P Jay, B C van de Weerdt, S Vainio, G P Nolan, H Clevers.   

Abstract

T cell factor / lymphocyte enhancer factor (Tcf/Lef) transcription factors complex with the transcriptional co-activator beta-catenin to transduce Wnt signals in a variety of developmental systems. The prototypic family member Tcf-1 is highly expressed in T lineage cells. Tcf1-/- mice are defective in cell cycling of early thymocyte stages. Here, we show that the interaction of beta-catenin with Tcf-1 is required for full thymocyte development. This interaction may be established by signals mediated by Wnt1 and Wnt4, leading to increased Tcf-dependent transcriptional activity in thymocytes, as demonstrated in Tcf-LacZ reporter mice. Transduction of fetal thymocytes with Wnt1 and Wnt4 results in increased survival in an in vitro cell culture system. Retroviral expression of soluble Wnt receptor mutants that block Wnt signaling inhibits thymocyte development. These results imply an important role for the Wnt cascade in thymocyte development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11265645     DOI: 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.0.CO;2-D

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  65 in total

Review 1.  Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.

Authors:  Luca Gattinoni; Yun Ji; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2010-08-05       Impact factor: 12.531

Review 2.  β-catenin/TCF-1 pathway in T cell development and differentiation.

Authors:  Jian Ma; Ruiqing Wang; Xianfeng Fang; Zuoming Sun
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-27       Impact factor: 4.147

3.  Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules.

Authors:  Floor Weerkamp; Miranda R M Baert; Brigitta A E Naber; Esther E L Koster; Edwin F E de Haas; Kondala R Atkuri; Jacques J M van Dongen; Leonard A Herzenberg; Frank J T Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

4.  Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.

Authors:  Sujatha Muralidharan; Patrick J Hanley; Enli Liu; Rikhia Chakraborty; Catherine Bollard; Elizabeth Shpall; Cliona Rooney; Barbara Savoldo; John Rodgers; Gianpietro Dotti
Journal:  J Immunol       Date:  2011-10-19       Impact factor: 5.422

Review 5.  Wnt signaling in normal and malignant hematopoiesis.

Authors:  William Lento; Kendra Congdon; Carlijn Voermans; Marcie Kritzik; Tannishtha Reya
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

6.  Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes.

Authors:  Yong-Tae Ahn; Boli Huang; Lisa McPherson; Carol Clayberger; Alan M Krensky
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

Review 7.  TCF1 and beta-catenin regulate T cell development and function.

Authors:  Qing Yu; Archna Sharma; Jyoti Misra Sen
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner.

Authors:  Dimple Notani; Kamalvishnu P Gottimukkala; Ranveer S Jayani; Amita S Limaye; Madhujit V Damle; Sameet Mehta; Prabhat Kumar Purbey; Jomon Joseph; Sanjeev Galande
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

9.  DKK1 mediated inhibition of Wnt signaling in postnatal mice leads to loss of TEC progenitors and thymic degeneration.

Authors:  Masako Osada; Logan Jardine; Ruth Misir; Thomas Andl; Sarah E Millar; Mark Pezzano
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 10.  Role of Wnt canonical pathway in hematological malignancies.

Authors:  Xueling Ge; Xin Wang
Journal:  J Hematol Oncol       Date:  2010-09-15       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.